Small molecule method development/synthetic reaction monitoring/Quality certification (QA) and quality control (QC)/impurity analysis/small molecule preparation and purification During the drug development process, method development will go through different stages, usually involving complex and variable samples. You need choose reliable and stable HPLC, UPLC, and GC to meet routine laboratory test

In the later development of drugs, quantitative bioanalysis using samples derived from PK research is an inevitable stage of drug development. Triple quadrupole is the product of choice and sensitivity is the most important indicator.

Generic drug conformity assessment (BE) In vivo bioequivalence test (in vivo BE): Whether the bioequivalence between the generic drug and the original drug was significantly different by liquid chromatography tandem mass spectrometry. Bioequivalence refers to the fact that under similar conditions, the absorption rate and degree of the test preparation (T) after a single dose or multiple doses of the same amount of the drug component are not significantly different from the reference preparation (R).